Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice.
We studied effect of pregnancy and ovariectomy on the development of mammary tumors in homozygous female HER-2/neutransgenic mice. The mean life span of uniparous mice was decreased by 16% in comparison to the control (P<0.05) and of mice which have two pregnancies decreased by 11% (P<0.05). Ovariectomy at the age of 2 months was followed by 32.7% increase in mean life span of mice. The incidence or multiplicity of mammary adenocarcinomas did not change in uniparous mice, whereas the size of the tumors and metastatic potential were decreased as compared to the virgins. When mice have two full-time pregnancies, there was an increase in multiplicity of mammary carcinomas and significant (2.1-fold) decrease in the survival time of tumor-bearing mice. Ovariectomy significantly decreased the total incidence of mammary carcinomas, the number of tumors per tumor-bearing animal, and inhibited metastasizing into lungs. Our results indicate that pregnancy accelerated the development of mammary adenocarcinomas in transgenic HER-2/neu mice whereas ovariectomy inhibits their development.
Anisimov
Vladimir N
VN
Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, Pesochny-2, St. Petersburg 197758, Russia. aging@mail.ru
Popovich
Irina G
IG
Alimova
Irina N
IN
Zabezhinski
Mark A
MA
Semenchenko
Anna V
AV
Yashin
Anatoli I
AI
D000367:Age Factors; D000818:Animals; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology*; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics*; D006720:Homozygote; D015674:Mammary Neoplasms, Animal / Q000235:genetics* / Q000473:pathology*; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000473:pathology*; D051379:Mice; D008822:Mice, Transgenic; D008962:Models, Theoretical; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology* / Q000601:surgery; D011247:Pregnancy; D011270:Pregnancy, Animal; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000502:physiology; D012307:Risk Factors; D013997:Time Factors
D018719:Erb-b2 Receptor Tyrosine Kinases